Association of chlamydial infection with cerebrovascular disease.
暂无分享,去创建一个
[1] D. Stewart,et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. , 1995, The Journal of infectious diseases.
[2] Y. Goo,et al. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[3] D. Strachan,et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. , 1995, The Journal of infection.
[4] H. Becher,et al. Recent infection as a risk factor for cerebrovascular ischemia. , 1995, Stroke.
[5] M. Leinonen,et al. Chlamydia pneumoniae multiplies in human endothelial cells in vitro. , 1994, Microbial pathogenesis.
[6] Y. Iijima,et al. Characterization of Chlamydia pneumoniae species-specific proteins immunodominant in humans , 1994, Journal of clinical microbiology.
[7] T. Tuomi,et al. Interference of immunoglobulin G (IgG) antibodies in IgA antibody determinations of Chlamydia pneumoniae by microimmunofluorescence test , 1994, Journal of clinical microbiology.
[8] P. Saikku. Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. , 1993, European heart journal.
[9] E. Benditt,et al. Chlamydia pneumoniae, strain TWAR and atherosclerosis. , 1993, European heart journal.
[10] M. Leinonen. Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. , 1993, European heart journal.
[11] A. Folsom,et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1993, The American journal of medicine.
[12] H. Fukushi,et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. , 1993, The Journal of infectious diseases.
[13] J. Grayston. Chlamydia in atherosclerosis. , 1993, Circulation.
[14] M. Nieminen,et al. Chlamydia Pneumoniae‐Specific Circulating Immune Complexes in Patients With Chronic Coronary Heart Disease , 1993, Circulation.
[15] D. Siscovick,et al. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. , 1992, JAMA.
[16] R. Snijder,et al. Age-related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor , 1992, Journal of clinical microbiology.
[17] M. Leinonen,et al. Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study , 1992, Annals of Internal Medicine.
[18] M. Golightly,et al. Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease , 1990, The Lancet.
[19] M. Nieminen,et al. SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.
[20] M. Kaste,et al. Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients , 1988, British medical journal.
[21] J. Altman,et al. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. , 1986, The New England journal of medicine.
[22] M. Leinonen,et al. The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria. , 1983, Science.